Publications by authors named "Michal Soczawa"
Vitamin D affects bone metabolism and calcium-phosphate metabolism. Its deficiency leads to bone mineralization disorders and is the cause of abnormal skeletal development from fetal life to the period of completed skeletal growth. In later periods of life, vitamin D deficiency leads to bone metabolism disorders, i.
View Article and Find Full Text PDFThe aim of the project was to evaluate the association between selenium (Se) and zinc (Zn) levels in blood and serum and kidney cancer mortality. In a prospective group of 284 consecutive, unselected patients with kidney cancer, we evaluated their 10-year survival rate in relation to the levels of Se and Zn in their blood and serum. Micronutrient levels were measured using an inductively coupled plasma mass spectrometer.
View Article and Find Full Text PDFIntroduction: The role of PALB2 in carcinogenesis remains to be clarified. Our main goal was to determine the prevalence of PALB2 (509_510delGA and 172_175delTTGT) mutations in bladder and kidney cancer patients from Polish population.
Materials And Methods: 1413 patients with bladder and 810 cases with kidney cancer and 4702 controls were genotyped for two PALB2 variants: 509_510delGA and 172_175delTTGT.
Introduction: Determining the clinical stage of bladder carcinoma before radical cystectomy is characterized by a high inaccuracy rate. The discrepancy in some reports reaches up to 48%. Therefore intraoperative clinical staging of bladder carcinoma is not recommended before radical treatment as it is for prostate cancer.
View Article and Find Full Text PDFUrolithiasis is a well-known disease. Stones can form in all parts of the urinary tract. Diagnosis and treatment usually do not create clinical problems.
View Article and Find Full Text PDFArticle Synopsis
- - The study investigated the Q548X mutation of the BLM gene in Polish men to see if it increases the risk of prostate cancer and affects survival rates.
- - The mutation was found in a small percentage (0.4%) of prostate cancer patients, with no significant difference in survival rates between those with and without the mutation.
- - The BLM Q548X mutation is common in Poland, but the research concluded it does not seem to predispose individuals to prostate cancer or influence survival outcomes.